Mary E. Wadlinger's most recent trade in LAVA Therapeutics NV was a trade of 33,390 Common Shares (Right to Buy) done . Disclosure was reported to the exchange on Feb. 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| LAVA Therapeutics NV | Mary E. Wadlinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 33,390 | 33,390 | - | - | Common Shares (Right to Buy) |